You are here

Valeant investors doubting drugmaker's chief can regain grip

The company is in worse shape after Michael Pearson returned from a two-month medical leave for pneumonia
Thursday, March 17, 2016 - 05:50

BT_20160317_DNVALEANT17_2170021.jpg
Mr Pearson said that due to the repercussions of a scandal concerning the mail-order pharmacy Philidor Rx Services LLC that was uncovered last year, the company would be late filing financial results.

Boston

MICHAEL Pearson and his company, Valeant Pharmaceuticals International Inc, were supposed to calm Wall Street doubters on Tuesday. Instead: chaos.

What began before dawn with disappointing financial news quickly snowballed into the worst day in the drug company's history,

sentifi.com

Market voices on:

Nespresso
Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at btsub.sg/btdeal

Powered by GET.comGetCom